Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-05-22
1997-04-22
Chang, Ceila
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514359, 514365, 514378, 514381, 514383, 514394, 514397, 514414, 514415, 548189, 548248, 5483051, 5483121, 548427, 548455, 548465, 548469, 548484, 548494, 548495, 548496, 548497, 5483611, A61K 31405, A61K 3141, C07D40312
Patent
active
056229836
ABSTRACT:
Novel unnatural dipeptoids of .alpha.-substituted Trp-Phe derivatives useful as agents in the treatment of obesity, hypersecretion of gastric acid in the gut, gastrin-dependent tumors, colorectal tumors, or as antipsychotics are disclosed. Further the compounds are antianxiety agents, antiulcer agents, antidepressant agents, and are agents useful for preventing the withdrawal response produced by chronic treatment or use followed by chronic treatment followed by withdrawal from nicotine, diazepam, alcohol, cocaine, caffeine, or opiods. Also disclosed are pharmaceutical compositions and methods of treatment using the dipeptoids as well as processes for preparing them and novel intermediates useful in their preparation. An additional feature of the invention is the use of the subject compounds to prepare pharmaceutical and diagnostic compositions.
REFERENCES:
patent: 3775466 (1973-11-01), Jager et al.
patent: 3839396 (1974-10-01), Otsuka et al.
patent: 4757151 (1988-07-01), Horwell
patent: 5218123 (1993-06-01), Horwell
patent: 5244915 (1993-09-01), Horwell
patent: 5264419 (1993-11-01), Horwell
patent: 5340825 (1994-08-01), Horwell
Bundgaard "Design of prodrugs" Elsevier, (1985) pp. 3, 346-353.
Notari et al "Biopharmaceutics and Pharmaco- kinetics" M. Decker Inc. (1975) pp. 216, 222.
Gould, et al., CA, 1979, 90:166522e/Tetrahedron Letters, 1978, 35, 3207-3210.
J. Hughes, et al., Proc Natl Acad Sci USA, 1990, 87, 6728-6732.
TiPS, 1990, 11, 271-273.
K.Q. Do, et al., CA, 1979, 91:57471n, 756.
W. Voelter & H. Kalbacher, CA, 1981, 94:140148v, 801.
G.W. Roberts, et al., Brain Research, 1983, 288, 199-211.
B.A. MacVicar, et al., Brain Research, 1987, 406, 130-135.
G.J. Dockray, British Med Bull, 1982, 38:3, 253-258.
P. Singh, et al., Cancer Research, 1986, 46, 1612-1616.
M.J. Sheehan, et al., CCK in the Nervous System, 1984, Ellis Horwood Ltd., Ch 7, 110-127.
J. Palmer Smith, et al., Gastroenterology, 1988, 95:6, 1541-1548.
V. Mutt, Gastrointestinal Hormones, 1980, Ch 7. 169-221.
L.R. Johnson, Ibid., Ch 22, 507-527. (1980).
S.J. Konturek, Ibid., Ch 23, 529-564. (1980).
F. Stadil, Ibid., Ch 30, 729-739. (1980).
K.Q. Do, et al., Helvetica Chimica Acta, 1979, 62:4, Nr 98.
J. E. Morley, Life Sciences, 1980, 27, 355-368.
J.F. Rehfeld & N.R. Goltermann, J of Neurochemistry, 32, 1339-1341. (1979).
R.G. Hill, et al., Neuropharmacology, 1987, 26:4, 289-300.
H. Demeulemeester, et al., J. of Neuroscience, 1988, 8:3, 988-1000.
S. Totterdell, et al., Neuroscience, 1986, 19:1, 181-192.
L.H. Schneider, et al., Peptides, 1983, 4, 749-753.
S.C. Harvey, Goodman & Gilman's Pharmacological Basis of Therapeutics,1985, 7th ed., Ch 17, 339-371.
F. Weiss, et al., Pharmacology Biochemistry & Behavior, 1988, 30, 309-317.
R.R. Schick, et al., Regulatory Peptides, 1986, 14, 277-291.
M.A. Della-Fera & C.A. Baile, Science, 1979, 206, 471-473.
Wall Street Journal, Sep. 29, 1989, B-3A, "Merck Advances . . . ".
Int J Cancer, 57, 1994, 1-7.
Aranda Julian
Horwell David C.
Pritchard Martyn C.
Richardson Reginald S.
Roberts Edward
Anderson Elizabeth M.
Chang Ceila
Warner-Lambert & Company
LandOfFree
N-substituted cycloalkyl and polycycloalkyl .alpha.-substituted does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with N-substituted cycloalkyl and polycycloalkyl .alpha.-substituted , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-substituted cycloalkyl and polycycloalkyl .alpha.-substituted will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-342106